Infectious Disease

Pre-clinical cancer-target validation

Published and unpublished studies by investigators in the pharmaceutical industry indicate that a disturbingly high number of academic laboratories’ reports nominating potential new cancer-drug targets are either

Long After Ebola ‘Cure,’ Neuro Effects Linger

Lee A. Norman, MD, MHS, MBA, discusses the possible Ebola survivor syndrome, the questions it raises about the virus’s persistence, and the implications of a post-Ebola syndrome.